The notices it replaced
- Reissues: PAR-22-119 Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
- 2 steps back: PAR-19-257 Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)
- 3 steps back: PAR-16-268 Limited Competition: Small Grant Program for NIAMS K08 and K23 Recipients (R03)
Replaced by PAR-27-074.
Who won it before
42 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,429,973 in first-year total cost, median $85,045.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Special Grants Study Section[AMS]42
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL5
- MASSACHUSETTS GENERAL HOSPITAL4
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO4
- JOHNS HOPKINS UNIVERSITY3
- YALE UNIVERSITY3
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Novel Modulators of Limb Development and Chondrocyte Maturation1R03AR085214-01 · under PAR-22-119 | RENTHAL, NORA EDWARDS | BOSTON CHILDREN'S HOSPITAL, MA | $177,000 | AMS |
| 2025 | Characterizing Injury-Related Fear in Patients after Anterior Cruciate Ligament Reconstruction1R03AR085215-01 · under PAR-22-119 | BAEZ, SHELBY | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $165,527 | AMS |
| 2025 | Glucagon-like peptide-1 receptor agonists in lupus1R03AR085677-01 · under PAR-22-119 | JORGE, APRIL | MASSACHUSETTS GENERAL HOSPITAL, MA | $165,000 | AMS |
| 2025 | Applying Service Design Methods to Enhance Implementation and Adoption of a Digital Graded Exposure Treatment for Youth with Chronic Musculoskeletal Pain in Clinical Settings1R03AR084020-01A1 · under PAR-22-119 | HARRISON, LAUREN ELISABETH | STANFORD UNIVERSITY, CA | $154,000 | AMS |
| 2024 | The role of UBR5 in skeletal muscle atrophy and regrowth1R03AR083980-01 · under PAR-22-119 | HUGHES, DAVID C | OKLAHOMA MEDICAL RESEARCH FOUNDATION, OK | $170,500 | AMS |
| 2024 | Systemic Treatments and Outcomes for Pediatric Atopic Dermatitis: Setting the Stage for Comparative Effectiveness Research1R03AR084585-01 · under PAR-22-119 | WAN, JOY | JOHNS HOPKINS UNIVERSITY, MD | $170,490 | AMS |
| 2024 | Examining endothelial cell and its plasticity in intramembranous bone regeneration1R03AR082927-01A1 · under PAR-22-119 | KO, FRANK | RUSH UNIVERSITY MEDICAL CENTER, IL | $158,000 | AMS |
| 2024 | Interrogation of T cell Bystander Activation in Scleroderma1R03AR083454-01 · under PAR-22-119 | ODELL, IAN D | YALE UNIVERSITY, CT | $147,400 | AMS |
| 2024 | Trained immunity as a link between Inflammatory Arthritis and development of Cardiovascular Disease1R03AR084000-01 · under PAR-22-119 | MACLAUCHLAN, SUSAN C. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $139,895 | AMS |
| 2024 | Endothelial Signaling in Exercise Metabolism1R03AR083493-01 · under PAR-22-119 | CRAIGE, SIOBHAN M | VIRGINIA POLYTECHNIC INST AND ST UNIV, VA | $72,753 | AMS |
| 2023 | Therapeutic potential of systemic and localized zinc delivery for modulating fracture repair1R03AR082449-01 · under PAR-22-119 | HAST, MICHAEL WILLIAM | UNIVERSITY OF PENNSYLVANIA, PA | $162,500 | AMS |
| 2023 | Role of antiviral signaling in psoriatic pathogenesis1R03AR082350-01 · under PAR-22-119 | RAZANI, BAHRAM | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $161,500 | AMS |
| 2023 | Illuminating IL-31-producing cells in allergic skin disease1R03AR082948-01 · under PAR-22-119 | FASSETT, MARLYS S | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $161,500 | AMS |
| 2023 | Mechanisms of reticulophagy and ER stress mitigation in epidermis1R03AR082896-01 · under PAR-22-119 | SIMPSON, CORY L | UNIVERSITY OF WASHINGTON, WA | $88,250 | AMS |
| 2023 | Evaluating the relationship between immune checkpoint inhibitors and osteoarthritis1R03AR081997-01 · under PAR-19-257 | CAPPELLI, LAURA CHRISTINE | JOHNS HOPKINS UNIVERSITY, MD | $81,875 | AMS |
| 2023 | Microbial metabolites impacting the response to methotrexate in rheumatoid arthritis1R03AR082036-01 · under PAR-19-257 | NAYAK, RENUKA RAJENDRA | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $80,750 | AMS |
| 2022 | Causal Inference for Better Understanding Clinical Trials Results: Reconciling Discrepant Comparative Evidence from Two Major Cardiovascular Safety Trials of Urate-Lowering Therapy1R03AR081309-01 · under PAR-19-257 | TEDESCHI, SARA K. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $89,500 | AMS |
| 2022 | Allele Specific Knockdown for LGMD-D11R03AR081395-01 · under PAR-19-257 | FINDLAY, ANDREW | WASHINGTON UNIVERSITY, MO | $78,729 | AMS |
| 2022 | Engineering recombinant lubricin to combat orthopedic infection1R03AR078961-01A1 · under PAR-19-257 | REESINK, HEIDI | CORNELL UNIVERSITY, NY | $78,500 | AMS |
| 2021 | Personalizing AAV Management by Leveraging Big Data: Targeting Complication Clusters1R03AR078938-01 · under PAR-19-257 | WALLACE, ZACHARY SCOTT | MASSACHUSETTS GENERAL HOSPITAL, MA | $105,843 | AMS |
| 2021 | Post-transcriptional Regulation of IL-21 in Human T Cells1R03AR078347-01 · under PAR-19-257 | RAO, DEEPAK ANGARA | BRIGHAM AND WOMEN'S HOSPITAL, MA | $89,500 | AMS |
| 2021 | Risk factors for anterior knee pain and the relation to future patellofemoral osteoarthritis1R03AR077698-01A1 · under PAR-19-257 | STEFANIK, JOSHUA JON | NORTHEASTERN UNIVERSITY, MA | $88,969 | AMS |
| 2021 | Atopic dermatitis in childhood and risk of early cardiovascular disease1R03AR078962-01 · under PAR-19-257 | ABUABARA, KATRINA ELAINE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $80,750 | AMS |
| 2021 | Enhancing Patient Education through a 'Journey Guide' For Adult Traumatic Brachia! Plexus Injury1R03AR077109-01A1 · under PAR-19-257 | DY, CHRISTOPHER JOHN | WASHINGTON UNIVERSITY, MO | $78,750 | AMS |
| 2021 | The Role of Biofilm Formation in Antibiotic Tolerant Periprosthetic Joint Infection1R03AR077602-01A1 · under PAR-19-257 | URISH, KENNETH L | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $78,250 | AMS |
| 2020 | Genetic and Functional Traits of Cultivated Nasal Bacteria in Relapsing Granulomatosis with Polyangiitis1R03AR077697-01 · under PAR-19-257 | RHEE, RENNIE | UNIVERSITY OF PENNSYLVANIA, PA | $102,186 | AMS |
| 2020 | Electron microscopy analysis of novel knob-pocket mechanism critical for intermediate filament assembly1R03AR076484-01 · under PAR-16-268 | BUNICK, CHRISTOPHER GERARD | YALE UNIVERSITY, CT | $83,750 | AMS |
| 2020 | Risk of Fractures and Joint Replacement Surgeries with TNF-inhibitor Use in Ankylosing Spondylitis1R03AR076495-01 · under PAR-16-268 | DUBREUIL, MAUREEN | BOSTON UNIVERSITY MEDICAL CAMPUS, MA | $82,500 | AMS |
| 2020 | Bone Turnover Responses to Sleep Restriction and Subsequent Sleep Recovery1R03AR074509-01A1 · under PAR-16-268 | SWANSON, CHRISTINE M | UNIVERSITY OF COLORADO DENVER, CO | $77,750 | AMS |
| 2020 | Role of the Alternative Complement Cascade in Connective Tissue Disease Associated Pulmonary Arterial Hypertension (CTD-PAH)1R03AR075866-01A1 · under PAR-19-257 | KORMAN, BENJAMIN DOUGLAS | UNIVERSITY OF ROCHESTER, NY | $77,000 | AMS |
| 2019 | Respiratory Diseases, Genetics, and Rheumatoid Arthritis Risk1R03AR075886-01 · under PAR-16-268 | SPARKS, JEFFREY ANDREW | BRIGHAM AND WOMEN'S HOSPITAL, MA | $89,500 | AMS |
| 2019 | The role of mitochondrial Damage Associated Molecular Patterns (mDAMPs) in posttraumatic osteoarthritis.1R03AR075929-01 · under PAR-16-268 | DELCO, MICHELLE LEE | CORNELL UNIVERSITY, NY | $78,500 | AMS |
| 2019 | CRISPR Screen to Identify Novel Secreted Epidermal Regulators1R03AR075844-01 · under PAR-16-268 | SUN, BRYAN | UNIVERSITY OF CALIFORNIA, SAN DIEGO, CA | $66,330 | AMS |
| 2018 | The role of 1,25 dihydroxyvitamin D in osteocyte perilacunar and canalicular remodeling1R03AR073899-01 · under PAR-16-268 | LIU, EVA S. | BRIGHAM AND WOMEN'S HOSPITAL, MA | $89,500 | AMS |
| 2018 | Dissecting the Temporal Role of Dermal Wnt/Beta-Catenin Signaling in Hair Follicle Induction During Development and Regenerative Wound Healing1R03AR072807-01 · under PAR-16-268 | MYUNG, PEGGY S | YALE UNIVERSITY, CT | $83,750 | AMS |
| 2018 | Reducing cartilage destruction in osteoarthritis with the small molecule SIK inhibitor YKL-05-0991R03AR072903-01 · under PAR-16-268 | WEIN, MARC NATHAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $83,596 | AMS |
| 2018 | Movement screening and modification in individuals with femoroacetabular impingement syndrome1R03AR072808-01 · under PAR-16-268 | LEWIS, CARA L | BOSTON UNIVERSITY (CHARLES RIVER CAMPUS), MA | $82,416 | AMS |
| 2018 | Angiogenic Potential in Children with Glucocorticoid-Induced Osteoporosis1R03AR073939-01 · under PAR-16-268 | CRANE, JANET | JOHNS HOPKINS UNIVERSITY, MD | $81,875 | AMS |
| 2018 | Cytosolic DNA sensors in cutaneous wound healing and host defense1R03AR073940-01 · under PAR-16-268 | SCUMPIA, PHILIP | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $78,000 | AMS |
| 2017 | Skeletal effects of the small molecule SIK inhibitor YKL-05-0991R03AR072150-01 · under PAR-16-268 | WEIN, MARC NATHAN | MASSACHUSETTS GENERAL HOSPITAL, MA | $85,339 | AMS |
| 2017 | Human Gut Microbiome as Modulator of Drug Response in Inflammatory Arthritis1R03AR072182-01 · under PAR-16-268 | SCHER, JOSE U. | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $84,750 | AMS |
| 2017 | Identification of BATF2 as a Regulator of Interferon-Enhanced Inflammatory Responses in Lupus Skin1R03AR072107-01 · under PAR-16-268 | KAHLENBERG, JOANNE MICHELLE | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $77,500 | AMS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.